Wealth Alliance Advisory Group, LLC Astrazeneca PLC Transaction History

Wealth Alliance Advisory Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$66.81 - $80.83 $187,068 - $226,324	2,800 New	2,800 $218,000
Q2 2023 Jul 13, 2023	BUY	$69.91 - $75.81 $195,748 - $212,268	2,800 New	2,800 $200,000
Q1 2022 Apr 18, 2022	SELL	$55.72 - $67.12 $278,321 - $335,264	-4,995 Closed	0 $0
Q4 2021 Jan 13, 2022	BUY	$54.02 - $63.83 $269,829 - $318,830	4,995 New	4,995 $291,000
Q2 2021 Jul 13, 2021	SELL	$48.42 - $60.18 $241,857 - $300,599	-4,995 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$48.52 - $58.02 $9,461 - $11,313	195 Added 4.06%	4,995 $250,000
Q3 2020 Oct 08, 2020	SELL	$53.07 - $61.1 $47,763 - $54,990	-900 Reduced 15.79%	4,800 $263,000
Q4 2018 Jan 28, 2019	BUY	$36.86 - $41.49 $210,102 - $236,493	5,700 New	5,700 $216,000

1,367

512M

6.08M

4.44M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $240B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Wealth Alliance Advisory Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Alliance Advisory Group, LLC with notifications on news.